Technology must make the Indian patent regime look sober & trustworthy to inventors
Novartis AG may be unhappy with the Indian patents’ regime
for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all.
Novartis AG may be unhappy with the Indian patents’ regime for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all. The applications need to be processed openly to obviate the doubts which may arise in the process.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
Novartis AG may be unhappy with the Indian patents’ regime
for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all.
Novartis AG may be unhappy with the Indian patents’ regime for refusing to grant patent rights to its cancer drug, Gilvec, but many others like the Swiss drug company, F. Hoffmann-La Roche Ltd., are a happy lot because they were successful in procuring the patent from Chennai branch of the office of Controller General of Patents, Designs & Trade Marks (CGPDTM) last year.
In 2005-06, the CGPDTM granted a staggering 4,320 patents – an increase of 125% over the 2004-05 figures. However, despite such impressive figures, the Indian patent rights organisation is being blamed from various quarters for being anything but transparent and reliable. “There are far too many problems associated with the whole process of getting your product patented in India. The procedural hassles eat into your time and the lack of openness in the system certainly raises doubts in the minds of the inventors. Furthermore, it is most disturbing when you have to run from pillar to post to get things done,” Dr. Subodh Sharma, a noted Pune based pharmacologist, who has been engaged in the process of drug registration for many years shared his views with B&E. Dr. Subodh’s view’s have been corroborated recently by the National Knowledge Commission.
The commission under the stewardship of Sam Pitroda has recommended Prime Minister Manmohan Singh to bring about some sweeping changes in the standard operating procedures being followed at the patents offices across India. The commission has unequivocally urged the government to introduce a fresh lease of life into Indian Intellectual Properties offices by making them more technology friendly. The commission feels that this needs to be implemented at an expeditious pace, because transparency needs to be introduced into the system and fair play ensured so that the competitors who raise objections against a particular application for patents get the feel that the system is fair to all. The applications need to be processed openly to obviate the doubts which may arise in the process.
For Complete IIPM Article, Click on IIPM Article
Source : IIPM Editorial, 2008
An IIPM and Professor Arindam Chaudhuri (Renowned Management Guru and Economist) Initiative
Read these article :-
ZEE BUSINESS BEST B SCHOOL SURVEY
B-schooled in India, Placed Abroad (Print Version)
IIPM in Financial times (Print Version)
IIPM makes business education truly global (Print Version)
The Indian Institute of Planning and Management (IIPM)
IIPM Campus
Top Articles on IIPM:-
IIPM makes business education truly global-Education-The Times of ...
The Hindu : Education Plus : Honour for IIPM
IIPM ranked No.1 B-School in India, Management News - By ...
IIPM Ranked No1 B-School in India
Moneycontrol >> News >> Press- News >> IIPM ranked No1 B-School in ...
IIPM ranked No. 1 B-school in India- Zee Business Survey ...
IIPM ranked No1 B-School in India :: Education, Careers ...
The Hindu Business Line : IIPM placements hit a high of over 2000 jobs
Deccan Herald - IIPM ranked as top B-School in India
India eNews - IIPM Ranked No1 B-School in India
IIPM Delhi - Indian Institute of Planning and Management New Delhi ...
domain-b.com : IIPM ranked ahead of IIMs
Read these article :-
ZEE BUSINESS BEST B SCHOOL SURVEY
B-schooled in India, Placed Abroad (Print Version)
IIPM in Financial times (Print Version)
IIPM makes business education truly global (Print Version)
The Indian Institute of Planning and Management (IIPM)
IIPM Campus
Top Articles on IIPM:-
IIPM makes business education truly global-Education-The Times of ...
The Hindu : Education Plus : Honour for IIPM
IIPM ranked No.1 B-School in India, Management News - By ...
IIPM Ranked No1 B-School in India
Moneycontrol >> News >> Press- News >> IIPM ranked No1 B-School in ...
IIPM ranked No. 1 B-school in India- Zee Business Survey ...
IIPM ranked No1 B-School in India :: Education, Careers ...
The Hindu Business Line : IIPM placements hit a high of over 2000 jobs
Deccan Herald - IIPM ranked as top B-School in India
India eNews - IIPM Ranked No1 B-School in India
IIPM Delhi - Indian Institute of Planning and Management New Delhi ...
domain-b.com : IIPM ranked ahead of IIMs
No comments:
Post a Comment